Not registered. Not advice. DecodeETF is an information service. We are not registered as an adviser, dealer, or investment fund manager with the Ontario Securities Commission or any Canadian provincial regulator. Nothing on this site is a recommendation, solicitation, or offer to buy or sell any security. Past performance is not indicative of future results, and all investing carries risk including the loss of principal. Speak with a registered financial professional before making investment decisions.
RBC iShares
An equity index fund: 47 stocks, 61% United States, unhedged, for 0.39% a year.
Funds of this type differ on a small set of facts. Where this fund sits on each:
Healthcare sector exposure. 100.0% of the portfolio is in Healthcare, so results largely reflected that part of the market. It tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index.
Top holding: Moderna Inc 4.8% (broad) · Top sector: Healthcare 100.0% (single-sector) · Top region: United States 60.5% (region-tilted)
Healthcare 100.0%
United States 60.5%·Europe 29.3%·Japan 5.9%·Emerging Markets 2.7%·Canada 1.6%
Source: fund provider disclosure.
The management fee was 0.39% a year, or about $39 for every $10,000 held. Trading spreads are separate from this fee. This is the management fee as published by the provider; the total expense ratio can be slightly higher once fund operating costs are added.
Mostly foreign income
The full distribution tax character across 4 years, plus what you keep after tax in a TFSA, RRSP, or non-registered account, is on the Real Yield report card.
See the full tax breakdown →For information only, not tax advice. Tax treatment depends on your account type and personal circumstances; consult a qualified tax professional.
How durable the fund is, and what moved its price.
| Assets | $11M· net assets |
| Listed | 2022· 4 years of history |
| Leverage / overlay | None |
What moved the price
| Ticker | XDNA.TO |
| Exchange | TSX |
| Currency | CAD |
| FX strategy | CAD-unhedged |
| Asset class | Equity |
| Structure | Physical (holds securities) |
| Theme | Biotech & Life Sciences |
| Geography | Global / World |
| Index tracked | NYSE FactSet Global Genomics and Immuno Biopharma Index |
| Provider | RBC iShares |
| Mgmt fee | 0.39% |
Compare XDNA.TO→Backtest it→Rate your portfolio→Real Yield report card→
Prices as of last close · tax character year 2025.
What Premium adds